How much revenue does Trident Lifeline make?

Trident Lifeline reported 1.29 billion INR in revenue for fiscal year 2026, up 48.4% from 869.65 million INR in fiscal year 2025.

What companies are similar to Trident Lifeline?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Themis Medicare Limited (THEMISMED.NS), Kilitch Drugs (India) Limited (KILITCH.NS), Albert David Limited (ALBERTDAVD.NS), Jenburkt Pharmaceuticals Limited (JENBURPH.BO).

Trident Lifeline Limited (TLL.BO) Stock

About Trident Lifeline Limited

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. It provides various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent...

At a glance

Trident Lifeline reported revenue of 1.29 billion INR for fiscal year 2026, up 48.4% from fiscal year 2025, and net income of 190.41 million INR.

Figures from company filings; latest fiscal year ended March 31, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.